Radixact Treatment Delivery System

Radixact Treatment Delivery System is an FDA 510(k)-cleared medical device (K223159) manufactured by Accuray Incorporated. This device is classified under the Radiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on June 22, 2023. Regulation: 8.